Skip to content
cccskills
FreePublished on GitHub

enda-follow-up-visits-age-based

Determines follow‑up interval for patients with primary adrenal insufficiency (PAI) based on age: annual visits for adults and children, and every 3–4 months for infants. Triggered when establishing routine endocrine care after PAI diagnosis or during stable management.

The English summary is being prepared. Showing the original description.

Run score Not tested

See how to install

Files included (1)

  • SKILL.md2.5 KB

SKILL.md (original)

Review the instructions the agent will receive before you install.

Schedule Follow-Up Visits Based on Age: Annual for Adults/Children, Every 3-4 Months for Infants

STEP 1 — Gather Information

Collect patient age, confirmed PAI diagnosis, and current clinical status (symptoms, growth parameters, recent illnesses).
Action: Proceed to age‑based classification.

STEP 2 — Rule In / Rule Out

Is the patient an infant (<12 months of age)?

  • Yes → infant pathway
  • No → adult/child pathway
    Action: If infant (<12 months), go to Step 3 for infant schedule; otherwise, go to Step 3 for adult/child schedule.

STEP 3 — Classify or Stratify

For infants: recommend follow‑up every 3–4 months.
For adults and children: recommend follow‑up at least annually.
Action: Assign follow‑up interval: every 3–4 months for infants; annually for adults and children.

STEP 4 — Decide

Schedule the next visit according to the determined interval and document the plan in the patient’s care plan.
Action: Schedule the next visit accordingly and document in the patient’s care plan.

Clinical Guardrails / Mimics / Pitfalls

  • Do not apply the same interval to all age groups; infants require more frequent assessment.
  • Avoid delaying infant visits beyond 4 months, as growth and adrenal crisis risk change rapidly.
  • Do not rely solely on patient‑reported symptoms; objective assessment (weight, blood pressure, developmental milestones) is essential.
  • Ensure visits are conducted by an endocrinologist or provider with endocrine expertise.
  • Do not skip scheduled visits during intercurrent illness without adjusting the plan; illness may necessitate earlier evaluation.

Concrete Clinical Example

A 6‑month‑old infant with newly diagnosed PAI is seen in clinic; per guideline, the next endocrine follow‑up is scheduled in 3 months. A 10‑year‑old child with stable PAI receives an annual visit schedule.

Source: Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, DOI:10.1210/jc.2015-1710

TODO: consider adding scripts/calc.py for the enda-follow-up-visits-age-based calculator

Reviews

No reviews yet. Tell others what you thought.

Comments

No login needed. Share how it worked for you, ask a question, or note where it did not run.

No comments yet. Be the first to write one.

Comments are published right away. Do not include personal information such as email addresses or phone numbers. Up to 2 URLs.

0 / 1,000 characters

This form is protected by reCAPTCHA, and the Google Privacy Policy and Terms of Service apply.

More skills from this repository

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

See all skills by dromlakhani

Report a problem with this skill